LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 8.98 | 17.25 | 1 | 445 | 0.0022 | -0.4552 | MN20160310_N02 | F13 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 8.98 | 17.25 | 545 | 445 | 1.2245 | 1.0883 | MN20160310_N02 | F13 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 8.98 | 17.25 | 1 | 445 | 0.0022 | -0.4552 | MN20160310_N02 | L16 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 8.98 | 17.25 | 930 | 445 | 2.0896 | 1.3404 | MN20160310_N02 | L16 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 10.95 | 17.25 | 1 | 471 | 0.0021 | -0.4494 | MN20160310_N02 | F13 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 10.95 | 17.25 | 641 | 471 | 1.3593 | 1.1329 | MN20160310_N02 | F13 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 10.95 | 17.25 | 1 | 471 | 0.0021 | -0.4494 | MN20160310_N02 | L16 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 10.95 | 17.25 | 940 | 471 | 1.9933 | 1.3110 | MN20160310_N02 | L16 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 12.91 | 17.25 | 1 | 494 | 0.0020 | -0.4446 | MN20160310_N02 | F13 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 12.91 | 17.25 | 737 | 494 | 1.4893 | 1.1715 | MN20160310_N02 | F13 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 12.91 | 17.25 | 1 | 494 | 0.0020 | -0.4446 | MN20160310_N02 | L16 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 12.91 | 17.25 | 952 | 494 | 1.9238 | 1.2894 | MN20160310_N02 | L16 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 14.88 | 17.25 | 1 | 534 | 0.0019 | -0.4373 | MN20160310_N02 | F13 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 14.88 | 17.25 | 793 | 534 | 1.4838 | 1.1659 | MN20160310_N02 | F13 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 14.88 | 17.25 | 1 | 534 | 0.0019 | -0.4373 | MN20160310_N02 | L16 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 14.88 | 17.25 | 979 | 534 | 1.8319 | 1.2600 | MN20160310_N02 | L16 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 16.85 | 17.25 | 1 | 655 | 0.0015 | -0.4188 | MN20160310_N02 | F13 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 16.85 | 17.25 | 812 | 655 | 1.2386 | 1.0832 | MN20160310_N02 | F13 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 16.85 | 17.25 | 1 | 655 | 0.0015 | -0.4188 | MN20160310_N02 | L16 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 16.85 | 17.25 | 1016 | 655 | 1.5498 | 1.1741 | MN20160310_N02 | L16 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 18.82 | 17.25 | 1 | 800 | 0.0012 | -0.4022 | MN20160310_N02 | F13 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 18.82 | 17.25 | 859 | 800 | 1.0731 | 1.0256 | MN20160310_N02 | F13 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 18.82 | 17.25 | 1 | 800 | 0.0012 | -0.4022 | MN20160310_N02 | L16 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 18.82 | 17.25 | 1034 | 800 | 1.2917 | 1.0946 | MN20160310_N02 | L16 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 20.79 | 17.25 | 1 | 1001 | 0.0010 | -0.3849 | MN20160310_N02 | F13 |